Penumbra Inc (PEN) - Total Liabilities

Latest as of June 2026: $443.96 Million USD

Based on the latest financial reports, Penumbra Inc (PEN) has total liabilities worth $443.96 Million USD as of June 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore PEN strategic capital deployment ratio to see how much of total assets are deployed in long-term investments.

Penumbra Inc - Total Liabilities Trend (2013–2025)

This chart illustrates how Penumbra Inc's total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see Penumbra Inc asset portfolio.

Penumbra Inc Competitors by Total Liabilities

The table below lists competitors of Penumbra Inc ranked by their total liabilities.

Company Country Total Liabilities
BorgWarner Inc
NYSE:BWA
USA $8.01 Billion
SK Telecom Co Ltd
KO:017670
Korea ₩16.94 Trillion
China Galaxy Securities Co Ltd Class A
SHG:601881
China CN¥707.95 Billion
BridgeBio Pharma Inc
NASDAQ:BBIO
USA $2.92 Billion
The Phoenix Holdings Ltd.
TA:PHOE
Israel ILA177.74 Billion
VERBUND AG ADR 1/5/O.N.
F:OEW
Germany €7.28 Billion
Lamar Advertising Company
NASDAQ:LAMR
USA $5.93 Billion
Embraer S.A.
SA:EMBR3
Brazil R$8.47 Billion

Liability Composition Analysis (2013–2025)

This chart breaks down Penumbra Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See Penumbra Inc (PEN) balance sheet quality index to measure how much of total assets are equity-financed.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric Value Description
Current Ratio 5.75 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 0.29 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.22 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Penumbra Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Penumbra Inc (2013–2025)

The table below shows the annual total liabilities of Penumbra Inc from 2013 to 2025.

Year Total Liabilities Change
2025-12-31 $398.92 Million +4.36%
2024-12-31 $382.25 Million +1.30%
2023-12-31 $377.36 Million +1.43%
2022-12-31 $372.03 Million +28.14%
2021-12-31 $290.32 Million +56.77%
2020-12-31 $185.19 Million +2.72%
2019-12-31 $180.29 Million +94.71%
2018-12-31 $92.59 Million +21.42%
2017-12-31 $76.26 Million +82.84%
2016-12-31 $41.71 Million +33.14%
2015-12-31 $31.33 Million -76.58%
2014-12-31 $133.75 Million +68.86%
2013-12-31 $79.21 Million --

About Penumbra Inc

NYSE:PEN USA Medical Devices
Market Cap
$12.56 Billion
Market Cap Rank
#1869 Global
#706 in USA
Share Price
$318.89
Change (1 day)
-0.26%
52-Week Range
$225.54 - $359.40
All Time High
$359.40
About

Penumbra, Inc., together with its subsidiaries, designs, develops, manufactures, and markets medical devices in the United States and internationally. It offers computer-assisted vacuum thrombectomy; peripheral thrombectomy products, including the Indigo System for power aspiration of thrombus in the body; Lightning Flash, a mechanical thrombectomy system; Lightning Bolt 7, an arterial thrombecto… Read more